Owner Eisai R & D Management Co., Ltd.

Inventors Miyagawa, Takehiko; Kitazawa, Noritaka; Kawano, Koki; Shin, Kogyoku; Doi, Eriko; Hagiwara, Hiroaki; Kimura, Teiji; Takaishi, Mamoru; Kaneko, Toshihiko; Sato, Nobuaki; Ito, Koichi; Sasaki, Takeo

Agent Davies Collison Cave

Pub. Number AU-A-2007252643

PCT Pub. Number WO2007/135969

Priority 2006-140479 19.05.06 JP

Filing date 18 May 2007

Wipo publication date 29 November 2007

C07D 233/64 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4178 (2006.01)

A61K 31/454 (2006.01)

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 249/06 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 249/08 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom